Company Filing History:
1 out of 191 
1 out of 832,880 Years Active: 1997-2002
Title: Michio Ohta: Innovator in Therapeutic and Antimicrobial Solutions
Introduction
Michio Ohta is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the fields of therapeutic drugs and antimicrobial compositions. With a total of 2 patents, his work focuses on addressing critical health challenges.
Latest Patents
One of his latest patents is for a therapeutic drug aimed at treating endotoxin blood symptoms and multi-organ failure. This innovative drug comprises sialic acid, its salts, and polymers of sialic acid as effective components. It demonstrates high therapeutic effects for shock death and organ failure induced by endotoxins, ensuring both efficacy and safety. Another notable patent involves antimicrobial compositions effective against methicillin-resistant Staphylococcus aureus (MRSA). These compositions utilize peptides isolated from horseshoe crabs combined with beta-lactam antibiotics and/or chloramphenicol antibiotics. They exhibit synergistic bactericidal effects against MRSA at low concentrations, making them valuable defensive agents against opportunistic infections.
Career Highlights
Throughout his career, Michio Ohta has worked with Seikagaku Corporation, where he has contributed to the development of innovative medical solutions. His expertise in therapeutic and antimicrobial research has positioned him as a key figure in the industry.
Collaborations
He has collaborated with notable individuals such as Nobuo Kato and Takaaki Hasegawa, further enhancing the impact of his work in the field.
Conclusion
Michio Ohta's contributions to therapeutic drugs and antimicrobial compositions highlight his role as an influential inventor. His innovative solutions continue to address significant health issues, showcasing the importance of research and development in medicine.